Literature DB >> 13950225

Dopamine metabolism in Parkinson's disease.

M GREER, C M WILLIAMS.   

Abstract

Entities:  

Keywords:  DOPA; DOPAMINE; PARALYSIS AGITANS; PHENYLACETATES

Mesh:

Substances:

Year:  1963        PMID: 13950225     DOI: 10.1212/wnl.13.1.73

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  13 in total

1.  [THE EFFICACY OF L-DOPA IN PARKINSON PATIENTS WITH AND WITHOUT STEREOTACTIC BRAIN SURGERY].

Authors:  W UMBACH; D BAUMANN
Journal:  Arch Psychiatr Nervenkr       Date:  1964-06-01

2.  [ADDITIONAL EXPERIMENTAL STUDIES ON L-DOPA IN PARKINSON'S SYNDROME AND RESERPINE PARKINSONISM].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Arch Psychiatr Nervenkr       Date:  1964-12-02

Review 3.  Challenges and recent advances in mass spectrometric imaging of neurotransmitters.

Authors:  Erin Gemperline; Bingming Chen; Lingjun Li
Journal:  Bioanalysis       Date:  2014-02       Impact factor: 2.681

4.  [Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes)].

Authors:  W Birkmayer; M Mentasti
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1967-08-08

5.  [Decreased homovanillic acid concentration in the brain in parkinsonian subjects as an expression of a disorder of central dopamine metabolism].

Authors:  H Bernheimer; O Hornykiewicz
Journal:  Klin Wochenschr       Date:  1965-07-01

6.  Dynamics of tyrosine hydroxylase mediated regulation of dopamine synthesis.

Authors:  Poorvi Kaushik; Fredric Gorin; Shireen Vali
Journal:  J Comput Neurosci       Date:  2007-04       Impact factor: 1.621

7.  Parkinsonism occurring during methyldopa therapy.

Authors:  R R Strang
Journal:  Can Med Assoc J       Date:  1966-10-29       Impact factor: 8.262

8.  A controlled study of L-DOPA in Parkinson's disease.

Authors:  W W Hofmann; R L Ryan
Journal:  Calif Med       Date:  1970-02

9.  Enhancement of anion binding in lanthanide optical sensors.

Authors:  Morgan L Cable; James P Kirby; Harry B Gray; Adrian Ponce
Journal:  Acc Chem Res       Date:  2013-09-16       Impact factor: 22.384

10.  Treatment of Parkinsonism with Laevo-dopa.

Authors:  C Mawdsley
Journal:  Br Med J       Date:  1970-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.